logo
Select company
Select metric
$ -31.83MFree Cash Flow
VS
Market
19
Sector
39
Industry
56
History
-
$ 2Close
$ 0.71 - $ 2.05 52-Week Range
Ticker Information

Ticker

IRD

Company Name

OPUS GENETICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

OPUS GENETICS INC - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

IRD - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 0$ -31.83M$ -31.83M
3/31/2025$ 0$ -28.85M$ -28.85M
12/31/2024$ 0$ -25.58M$ -25.58M
9/30/2024$ 0$ -13.59M$ -13.59M
6/30/2024$ 0$ -11.46M$ -11.46M
3/31/2024$ 0$ -3.18M$ -3.18M
12/31/2023$ 0$ -1.11M$ -1.11M
9/30/2023$ 0$ 23.13M$ 23.13M
6/30/2023$ 0$ 21.64M$ 21.64M
3/31/2023$ 0$ 16.84M$ 16.84M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • OPUS GENETICS INC's latest trailing twelve months (TTM) FCF stands at $ -5.85M.
  • Over the past 5 years, OPUS GENETICS INC's average FCF has been $ -8.62M.
  • The median FCF for OPUS GENETICS INC during this period was $ -12.53M
  • OPUS GENETICS INC reached its highest FCF over the past 5 years at $ 23.13M.
  • The lowest FCF recorded by OPUS GENETICS INC in the same timeframe $ -31.83M

OPUS GENETICS INC's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
VRCA : VERRICA PHARMACEUTICALS INC $ -47.35MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -38.55MEQ : EQUILLIUM INC $ -22.15MHYFT : MINDWALK HOLDINGS CORP $ -6.97MXLO : XILIO THERAPEUTICS INC $ -13.77MCUE : CUE BIOPHARMA INC $ -28.22MSRZN : SURROZEN INC $ -18.73MWHWK : WHITEHAWK THERAPEUTICS INC $ -96.49MOVID : OVID THERAPEUTICS INC $ -40.09MSEER : SEER INC $ -53.79M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for OPUS GENETICS INC is calculated as follows: CF - Operations [ $ -5.85M ] - CapEx [ $ 0 ]
(=) FCF [ $ -5.85M ]

IRD - Free Cash Flow, Last 5 years

$ -31.83M

Minimum

Jun 30, 2025

$ 23.13M

Maximum

Sep 30, 2023

$ -8.62M

Average

$ -12.53M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.84M with a standard deviation of $ 118.01M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.84M
median$ 464K
std$ 118.01M